Cancer Genetics Inc
CGIX
Delayed Nasdaq - 02/22 07:19:40 pm
1.8USD
+2.86%
Upcoming events

- No events available -

Past Events
12/14/17Benchmark Company, LLC Micro Cap Discovery Conference
12/05/17 | 06:00pmLD Micro Conference
11/09/17 | 02:30pmQ3 2017 Earnings Call
11/09/17Q3 2017 Earnings Release
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
27,0
26,9
0,55%

30,8
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-14,3
-14,5
1,0%

-7,57
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-16,7
-17,0
1,3%

-11,7
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-16,7
Net income
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-15,7
EPS
 $
Released
Forecast
Spread
-1,00
-1,10
9,1%

-0,71
Announcement Date03/23/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
8,03
7,91
1,5%

9,19
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-2,67
-1,91
-39%

-1,53
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-3,19
-2,67
-20%

-2,58
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-0,63
-2,80
77%

-2,83
Net income
Million $
Released
Forecast
Spread
-0,63
-2,80
77%

-2,83
EPS
 $
Released
Forecast
Spread
-0,15
-0,12
-22%

-0,11
Announcement Date11/09/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise